Correlation Between Equillium and Jasper Therapeutics
Can any of the company-specific risk be diversified away by investing in both Equillium and Jasper Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Equillium and Jasper Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Equillium and Jasper Therapeutics, you can compare the effects of market volatilities on Equillium and Jasper Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Equillium with a short position of Jasper Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Equillium and Jasper Therapeutics.
Diversification Opportunities for Equillium and Jasper Therapeutics
-0.13 | Correlation Coefficient |
Good diversification
The 3 months correlation between Equillium and Jasper is -0.13. Overlapping area represents the amount of risk that can be diversified away by holding Equillium and Jasper Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Jasper Therapeutics and Equillium is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Equillium are associated (or correlated) with Jasper Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Jasper Therapeutics has no effect on the direction of Equillium i.e., Equillium and Jasper Therapeutics go up and down completely randomly.
Pair Corralation between Equillium and Jasper Therapeutics
Allowing for the 90-day total investment horizon Equillium is expected to under-perform the Jasper Therapeutics. In addition to that, Equillium is 2.57 times more volatile than Jasper Therapeutics. It trades about -0.26 of its total potential returns per unit of risk. Jasper Therapeutics is currently generating about 0.02 per unit of volatility. If you would invest 2,202 in Jasper Therapeutics on August 27, 2024 and sell it today you would earn a total of 3.00 from holding Jasper Therapeutics or generate 0.14% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Equillium vs. Jasper Therapeutics
Performance |
| Timeline |
| Equillium |
| Jasper Therapeutics |
Equillium and Jasper Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Equillium and Jasper Therapeutics
The main advantage of trading using opposite Equillium and Jasper Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Equillium position performs unexpectedly, Jasper Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Jasper Therapeutics will offset losses from the drop in Jasper Therapeutics' long position.| Equillium vs. Eliem Therapeutics | Equillium vs. HCW Biologics | Equillium vs. Scpharmaceuticals | Equillium vs. Milestone Pharmaceuticals |
| Jasper Therapeutics vs. Lyra Therapeutics | Jasper Therapeutics vs. Equillium | Jasper Therapeutics vs. Hookipa Pharma | Jasper Therapeutics vs. Acumen Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Other Complementary Tools
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |